To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention for fiscal year 2024.

Bill 118 hr 1962, also known as the "Limitation on Availability of Funds for CDC HIV/AIDS, Viral Hepatitis, STDs, and TB Prevention Act of 2024," aims to restrict the amount of funds available for the Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), for the prevention of HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for the fiscal year 2024.

The bill seeks to impose limitations on the allocation of funds to these specific areas of public health, potentially impacting the CDC's ability to effectively combat these diseases. It is important to note that this bill does not eliminate funding entirely, but rather places restrictions on the amount of funds that can be allocated for these specific purposes.

The rationale behind this limitation is not explicitly stated in the bill itself, but it may be related to budgetary concerns, shifting priorities within the Department of Health and Human Services, or a desire to reallocate funds to other areas of public health. Overall, Bill 118 hr 1962 represents a significant potential change in the funding landscape for HIV/AIDS, viral hepatitis, STDs, and TB prevention efforts in the United States for the fiscal year 2024. It will be important to monitor the impact of this bill on public health outcomes and the CDC's ability to effectively address these critical health issues.